Stanford Medicine professionals are investigating whether a drug called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce transmission of the virus.

The drug is a manufactured form of a naturally occurring protein that’s been given in previous clinical trials of people infected with hepatitis viruses.

For more KCBS news anchor Susan Leigh Taylor spoke with Dr. Upi Singh, co-leader of the study and professor of infectious diseases at the Stanford Medical School.

Stanford Medicine professionals are investigating whether a drug called interferon-lambda can help people with mild cases of COVID-19 feel better and reduce transmission of the virus.
The drug is a manufactured form of a naturally occurring protein that&rsquo;s been given in previous clinical trials of people infected with hepatitis viruses.
For more KCBS news anchor Susan Leigh Taylor spoke with Dr. Upi Singh, co-leader of the study and professor of infectious diseases at the Stanford Medical School.

KCBS Radio: On-Demand

Today's news from KCBS Radio in the palm of your hand.

Advertisement